# University of New Orleans

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-of-new-orleans/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 84.8 |
| Citations | 1,165,144 |
| City | New Orleans |
| Country | US |
| Description | University of New Orleans is a research organisation in New Orleans, US. OpenAlex records 21,651 works and 1,165,144 citations for it. 3,873 researchers list it as their most recent affiliation. |
| Homepage | http://www.uno.edu/ |
| OpenAlex ID | https://openalex.org/I192396691 |
| Researchers | 3,873 |
| ROR ID | https://ror.org/034mtvk83 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q1474157 |
| Works | 21,651 |

## University papers

- [Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues](https://scholariq.org/papers/clades-of-adeno-associated-viruses-are-widely-disseminated-in-human-tissues/)
- [Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer](https://scholariq.org/papers/safety-and-feasibility-of-crispr-edited-t-cells-in-patients-with-refractory-non/)
- [Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial](https://scholariq.org/papers/gefitinib-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-egfr-mutation/)
- [Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)](https://scholariq.org/papers/efficacy-and-safety-of-sintilimab-plus-pemetrexed-and-platinum-as-first-line/)
- [BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/beyond-a-randomized-double-blind-placebo-controlled-multicenter-phase-iii-study/)
- [Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-a-predominantly-chinese-patient-population-with/)
- [Adeno-associated viruses undergo substantial evolution in primates during natural infections](https://scholariq.org/papers/adeno-associated-viruses-undergo-substantial-evolution-in-primates-during/)
- [AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations](https://scholariq.org/papers/aeneas-a-randomized-phase-iii-trial-of-aumolertinib-versus-gefitinib-as-first/)
- [Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)](https://scholariq.org/papers/anlotinib-as-a-third-line-therapy-in-patients-with-refractory-advanced-non-small/)
- [Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer](https://scholariq.org/papers/randomized-trial-of-first-line-tyrosine-kinase-inhibitor-with-or-without/)
- [Pseudo-small cell transformation in EGFR-mutant adenocarcinoma](https://scholariq.org/papers/pseudo-small-cell-transformation-in-egfr-mutant-adenocarcinoma/)

## University researchers

- [You Lü](https://scholariq.org/researchers/you-lu/)

## University top topics

Showing 8 of 23.

- [Advanced Chemical Physics Studies](https://scholariq.org/topics/advanced-chemical-physics-studies/)
- [Islamic Finance and Banking Studies](https://scholariq.org/topics/islamic-finance-and-banking-studies/)
- [Target Tracking and Data Fusion in Sensor Networks](https://scholariq.org/topics/target-tracking-and-data-fusion-in-sensor-networks/)
- [Child and Adolescent Psychosocial and Emotional Development](https://scholariq.org/topics/child-and-adolescent-psychosocial-and-emotional-development/)
- [Corporate Finance and Governance](https://scholariq.org/topics/corporate-finance-and-governance/)
- [Underwater Acoustics Research](https://scholariq.org/topics/underwater-acoustics-research/)
- [Banking stability, regulation, efficiency](https://scholariq.org/topics/banking-stability-regulation-efficiency/)
- [Financial Markets and Investment Strategies](https://scholariq.org/topics/financial-markets-and-investment-strategies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.